Lori Downing, LCADC is a
Counselor - Addiction (substance Use Disorder) based in Brigantine, New Jersey. Lori Downing is licensed to practice in New Jersey (license number 37LC00369600) and her current practice location is
825 W Shore Dr, Brigantine, New Jersey. She can be reached at her office (for appointments etc.) via phone at
(609) 536-9307.
NPI number for Lori Downing is 1629919394 and her current mailing address is 825 W Shore Dr, Brigantine, New Jersey. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1629919394.
Healthcare Provider's Profile
| Full Name | Lori Downing |
|---|
| Gender | Female |
|---|
| Speciality | Counselor - Addiction (substance Use Disorder) |
|---|
| Location | 825 W Shore Dr, Brigantine, New Jersey |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1629919394
- Provider Enumeration Date: 04/04/2026
- Last Update Date: 04/04/2026
Medical Identifiers
Medical identifiers for Lori Downing such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
| 1629919394 | NPI | - | NPPES |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 37LC00369600 (New Jersey) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lori Downing is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
Lori Downing, LCADC 825 W Shore Dr, Brigantine, NJ 08203-2624 Ph: (215) 801-1703 | Lori Downing, LCADC 825 W Shore Dr, Brigantine, NJ 08203-2624 Ph: (609) 536-9307 |
Reviews and Comments